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Aldosterone-producing adrenal adenoma can induce various clinical manifestations
as a result of chronic exposure to aldosterone. We report a rare case of a 37-year-old
man who complained of general weakness and polyuria. He was diagnosed with
aldosterone-producing adrenal adenoma and nephrogenic diabetes insipidus.
Aldosterone enhances the secretion of potassium in the collecting duct, which
can lead to hypokalemia. By contrast, nephrogenic diabetes insipidus, which
manifests as polyuria and polydipsia, can occur in several clinical conditions such
as acquired tubular disease and those attributed to toxins and congenital causes.
Among them, hypokalemia can also damage tubular structures in response to
vasopressin. The patient’s urine output was 43 L/d and was diluted. Owing to the
ineffectiveness of vasopressin, we eventually made a diagnosis of nephrogenic
diabetes insipidus. Laparoscopic adrenalectomy and intraoperative kidney biopsy
were subsequently performed. The pathologic ﬁnding of kidney biopsy revealed a
decrease in aquaporin-2 on immunohistochemical stain.
& 2014. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Primary aldosteronism is characterized by hypertension,
hypokalemia, and sodium retention resulting from chronic
oversecretion of aldosterone. In most cases, primary aldoster-
onism is due to a unilateral adrenal adenoma (65–75%), an
idiopathic bilateral adrenal hyperplasia (33%), or—in rare cases
—an adrenal carcinoma or aldosterone-producing ovarian
cancer [1]. These cases typically present with symptoms of
muscle weakness, paralysis, polyuria, headache, and sensory
disturbances. Most patients had hypertension, but some had
also had tetany and paralysis. The clinical symptoms asso-
ciated with hypokalemia include muscle weakness, paralysis,n Society of Nephrology. Publi
c-nd/4.0/).
rology, Korea University
ong, Danwon-gu, Ansan
).
this work.rhabdomyolysis, arrhythmia, impaired urinary concentration,
and hyperglycemia [1]. Therefore, most patients with primary
aldosteronism are admitted to hospitals for headaches related
to hypertension or symptoms associated with hypokalemia [1].
We report a rare case of a patient with primary aldosteronism
who presented with hypokalemia and diabetes insipidus (DI).
Interestingly, this patient was found to have a water channel
aquaporin-2 (AQP2) deﬁciency during the immunohistochemical
examination of the kidney. We also reviewed several reports of
primary aldosteronism associated with either hypokalemia or
acquired nephrogenic DI.Case report
A 37-year-old man with a history of hypertension was
admitted to the emergency department for symptoms of
muscle weakness and paralysis. He had been diagnosed with
hypertension at 28 years of age. His blood pressure had beenshed by Elsevier. This is an open access article under the CC BY-NC-ND
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had been suffering from muscle weakness and paralysis for
several years.
On examination, his blood pressure was 150/90 mmHg and his
heart rate was 64 beats/min. His laboratory blood chemistry
results revealed a low potassium level, Na 147 mmol/L, K
1.91 mmol/L, Cl 108 mmol/L, and total CO2 27.8 mmol/L. However,
calcium (8.7 mg/dL), magnesium (2.2 mg/dL), and phosphorus
(3.8 mg/dL) were within normal levels. The arterial blood gas
analysis showed the following values—pH 7.435, PCO2 46.5 mmHg,
PO2 87.7 mmHg, HCO3 30.5 mmol/L, O2 saturation 97.1%—which
indicated metabolic alkalosis. Other studies included BUN/creati-
nine level of 11/0.7 mg/dL, and the urinary chemistry proﬁle
showed a high potassium level of 18.56 mmol/L, a low urine
osmolality of 199 mOsm/kg, and a transtubular potassium con-
centration gradient of 20. On the 2nd day of hospitalization, the
collected 24-hour urine test revealed the following values:
creatinine 317 mmol/d, urea nitrogen 2,834 mg/d, sodium
322 mmol/d, potassium 88mmol/d, calcium 379 mg/d; moreover,
proteinuria was not detected. The patient’s thyroid hormone level
was within normal limits. His plasma aldosterone (PA) level was
224.7 pg/dL and the plasma renin activity (PRA) was as low as
0.11 ng/mL, resulting in a high PA/PRA ratio. Even though a
saline loading test showed an intermediate aldosterone level
(7.68 ng/dL), a left adrenal mass measuring 2 cmwas observed in
abdominal computed tomography (CT; Fig. 1).
Although the patient had not noticed any polyuria, his
urinary volume was 43 L/d during his admission. His anti-
diuretic hormone (ADH) level rose (224.7 pg/mL). His brain
magnetic resonance imaging result showed a normal pituitary
gland, and he had an insigniﬁcant response to the water
deprivation test after stimulation by vasopressin injection.
This ruled out central DI and suggested nephrogenic DI. The
patient received potassium infusions, and his potassium level
improved from 1.91 mmol/L to 3.86 mmol/L. Subsequently, the
patient was placed on 50 mg spironolactone daily.
Finally, a laparoscopic-assisted left adrenalectomy was
performed, and the corresponding biopsy revealed it to
be an adenoma (Fig. 2). We also needed to prove that
aldosteronism, hypokalemia, and DI occurred sequentially.
According to Marples et al [2], prolonged hypokalemia resulted
in the downregulation of AQP-2 expression in a rat kidney.Figure 1. Abdominal computed tomography (CT). (A) An approximately 2-cm
precontrast CT. (B) No deﬁnite enhancement was observed on dynamic CT imagHowever, this has not been demonstrated in humans; there-
fore, a renal biopsy was also performed during the laparoscopy
to investigate potential renal pathology.
There were approximately 46 glomeruli, eight of which
were completely sclerotic. Many of the remaining glomeruli
showed elongated cigar-shaped capillary loops with mesan-
giolysis. There were no segments of sclerosis, adhesion, or
crescents. Capillary walls and basement membranes were
thickened but singly contoured. Many proximal tubules were
ﬂattened with a loss of brush borders and were detached from
the tubular basement membranes. The others had markedly
swollen cytoplasm, resulting in luminal narrowing, in which
brush borders were well preserved. The interstitium was
markedly edematous and inﬁltrated by lymphocytes. In terms
of water channels in the kidney, the immunohistochemistry
showed that AQP-2 expression was signiﬁcantly decreased, but
that of other AQP channels, AQP-1 or AQP-3, was not different
compared to that in a healthy kidney (Fig. 3). On the 3rd day
after surgery, the serum potassium level normalized to
4.5 mmol/L without replacement of potassium, the PA level
decreased to 26.7 pg/dL, and PRA increased to 0.37 ng/mL,
resulting in a lower PA/PRA ratio. Urine output also decreased
to o2 L/d, and the patient was discharged from the hospital.Discussion
This is a rare case where acquired nephrogenic DI associated
with chronic hypokalemia was caused by an aldosterone-
secreting adrenal adenoma.
Primary aldosteronism refers to conditions in which the
production of aldosterone, a steroid hormone produced in the
adrenal gland, is inappropriately high. Such overproduction of
aldosterone causes cardiovascular damage, hypertension,
sodium retention, and potassium excretion that, if prolonged
and severe, may lead to signiﬁcant potassium deﬁciency [1].
Hypokalemia is one of the most important symptoms of
primary aldosteronism. The mechanism of hypokalemia is
usually explained by accelerated potassium excretion into
renal distal tubules in response to aldosterone excess. The
arterial hypertension of primary hyperaldosteronism is
explained by an increase in sodium reabsorption related tomass lesion is noted at the left adrenal gland, which has a low density on
e. This is a small adrenal mass lesion (benign rather than malignant).
Figure 2. Adrenal biopsy ﬁndings from a patient with primary aldosteronism. (A) The specimen of an enlarged adrenal gland, measuring 5.7
cm3.2 cm1.8 cm, shows its external surface with a focally polypoid appearance. The cut surface shows a relatively well-capsulated diffuse bright
yellowish solid mass, measuring 2.0 cm1.7 cm across. (B) Adrenal biopsy shows cells uniform in size and shape that resemble mature cortical cells.
Occasionally, there is some nuclear and cellular pleomorphism but with no evidence of anaplasia. They have uniform nuclei and well-differentiated,
abundant cytoplasm (producing cholesterol-rich materials such as hormones).
Figure 3. Renal biopsy ﬁndings from a patient with primary aldosteronism. (A) The biopsy specimen for conventional light microscopy shows no
segments of sclerosis, adhesion, or crescents. Other structures such as capillary walls and basement membranes, tubules, and cytoplasm are
preserved or mildly changed. However, there is a patchy area of chronic inﬂammatory changes such as glomerular sclerosis, tubular atrophy, and
associated interstitial ﬁbrosis (periodic acid-Schiff stain, 200). (B) The normal kidney biopsy from control person using immunohistochemistry for
aquaporin-2 (AQP-2) shows normal expression ( 200). (C) The patient’s renal biopsy reveals decreased AQP-2 expression, compared to that in a
normal kidney using immunohistochemistry (200).
Kim et al / Primary aldosteronism 231the effect of aldosterone on distal renal tubules. This transient
hypervolemia, along with the direct effects of aldosterone,
induces secretion of natriuretic factors such as atrialnatriuretic peptides [3]. Blood pressure remains high owing
to several factors, including increased peripheral vascular
resistance, a direct hypertensive effect of aldosterone on the
Kidney Res Clin Pract 33 (2014) 229–233232central nervous system, and increased vascular sensitivity to
pressor substances such as angiotensin and adrenalin. How-
ever, the clinical and biological spectrum of primary aldoster-
onism varies [3]. In particular, hypokalemia is present in 7–38%
of patients with primary aldosteronism, ranging from
1.4 mmol/L to 3.5 mmol/L. In most cases, younger patients
were diagnosed by high blood pressure and neuromuscular
signs and symptoms associated with hypokalemia.
Primary aldosteronism is commonly caused by benign
tumors of the adrenal gland, overactivity of steroid-
producing cells in the adrenal cortex, or—in rare cases—
hereditary conditions or adrenal cancer [1]. PRA can be
measured as a screen for primary aldosteronism. Although
members of the general population have PRA levels o1.0–
2.0 ng/mL/h, 25% of patients with essential hypertensive show
decreased PRA and increased aldosterone levels [1]. To differ-
entiate these diseases, the PA/PRA ratio should be examined.
Primary aldosteronism is possible if the ratio exceeds 30. It is
strongly suggested when the ratio is 450.
An adrenal CT scan should be examined to classify the
subtype, identify the location, and rule out adrenal cortical
carcinoma [1]. In the case of an aldosterone-secreting ade-
noma, a unilateral adrenal adenoma was reported that mea-
sured 1.8 cm on average and o1 cm in 19% of patients.
Primary aldosteronism usually occurs from an adenoma or a
bilateral hyperplasia. Adrenal adenoma is generally treated
with surgery via a unilateral approach, whereas bilateral
hyperplasia is treated with medical therapy. However, there
are limitations to diagnosing adrenal adenomas with CT,
because it is still difﬁcult to discover the location between
the right and left sides, and even more difﬁcult to diagnose
bilateral hyperplasia. Therefore, adrenal venous sampling
might be the most accurate and deﬁnitive diagnosis tool for
small adenomas and bilateral hyperplasia. However, in the
case of highly suspicious aldosterone-secreting adenomas, if
the mass is well deﬁned, hypodense, and 41 cm on CT scan,
then laparoscopic adrenalectomy can be considered, and
adrenal venous sampling can be bypassed [1].
By contrast, acquired nephrogenic DI results from a decreased
expression of AQP-2, which leads to impairment of urinary
concentration. AQP-2 (water channel proteins) are located in the
principal cells of the collecting duct, and they regulate water
permeability. When ADH binds to type 2 vasopressin receptor on
the basolateral membrane of the principal cell, AQP-2 are carried
by cytoplasmic vesicles and then distributed into the apical
membrane. Water in the apical membrane enters through AQP-
2 and exits into the basolateral membrane through AQP-3 and -4
[4]. Hypokalemia seems to cause a reduction in the intracellular
level of cAMP, which acts as the second messenger for ADH. It
then leads to the downregulation of AQP-2. This mechanism is
similar to that of lithium-induced nephrogenic DI; however,
hypokalemia-induced DI is believed to have a relatively modest
effect compared with lithium, and complete recovery is possible
when hypokalemia is corrected [2].
Hyperaldosteronism most commonly occurs from second-
ary causes and can result in severe complications. Several
cases complicated with secondary hypertension by adrenal
adenoma have been reported in Korea: aortic dissection, one of
severe left ventricular septal hypertrophy, basal ganglia intra-
cranial hemorrhage, and two cases of preeclampsia [5–8].
Moreover, hypokalemia due to hyperaldosteronism has been
reported in several case studies with periodic paralysis, two
cases of rhabdomyolysis, and one instance of cardiac arrestduring adrenalectomy [9–11]. A case of nephrocalcinosis and
renal cyst was reported related to hypokalemia [12].
Chronic hypokalemia leading to acquired nephrogenic DI
was reported in a patient with renal artery stenosis in Korea
[13]. Furthermore, several cases of renal disease related to
hypokalemic nephrogenic DI, without conﬁrmed hyperaldos-
teronism, have been reported in patients with multiple
autoimmune syndrome and multiple myeloma [14,15]. Inter-
estingly, in our case, renal biopsy showed evidence of chronic
renal tubulointerstitial injury and decreased expression of
AQP-2 in the renal collecting tubules.
In summary, the authors conﬁrmed an adrenal adenoma in
a patient with hypertension and hypokalemia using CT for
investigation of the potential causes of primary aldosteronism.
Moreover, chronic renal tubulointerstitial injury and AQP-2
deﬁciency developed because of chronic hypokalemia asso-
ciated with primary aldosteronism.Conﬂict of interest
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